Me. Rev. Stat. tit. 32, § 13844 (2025)
1. Generally accepted standards of care A pharmacist may engage in collaborative drug therapy management pursuant to a collaborative practice agreement only for conditions or diseases with generally accepted standards of care.
[PL 2013, c. 308, §4 (NEW).]
2. Prohibition A pharmacist who is engaged in collaborative drug therapy management pursuant to a collaborative practice agreement may not, as part of the collaborative practice, participate in research or clinical or investigational trials.
[PL 2013, c. 308, §4 (NEW).]
3. Limitation A collaborative practice agreement may include only the conditions or diseases to be managed that meet the qualifications and scope of practice for each party to the agreement.
[PL 2013, c. 308, §4 (NEW).]
PL 2013, c. 308, §4 (NEW).